Skip to main content

Advertisement

ADVERTISEMENT

News

News
04/05/2024

Attune Medical Press Release 

Attune Medical Press Release 
CHICAGO -- Heart Rhythm Clinical and Research Solutions (HRCRS) and the Real World Evidence (RWE) Consortium have enrolled the first patient in the REView of ProcEdural FactoRs and Outcomes after Atrial Fibrillation Ablation with Active...
CHICAGO -- Heart Rhythm Clinical and Research Solutions (HRCRS) and the Real World Evidence (RWE) Consortium have enrolled the first patient in the REView of ProcEdural FactoRs and Outcomes after Atrial Fibrillation Ablation with Active...
CHICAGO -- Heart Rhythm Clinical...
04/05/2024
EP Lab Digest
News
04/05/2024

Johnson & Johnson Press Release 

Johnson & Johnson Press Release  ...
Enhances Johnson & Johnson’s Ability to Transform the Treatment Landscape for Cardiovascular Disease and Continue to Improve Patient Outcomes Extends Johnson & Johnson MedTech’s Position in Highest-Growth, Innovation-Oriented Segments of...
Enhances Johnson & Johnson’s Ability to Transform the Treatment Landscape for Cardiovascular Disease and Continue to Improve Patient Outcomes Extends Johnson & Johnson MedTech’s Position in Highest-Growth, Innovation-Oriented Segments of...
Enhances Johnson & Johnson’s...
04/05/2024
EP Lab Digest
News
03/28/2024

Viz.ai, Inc. Press Release

Viz.ai, Inc. Press Release
Collaboration aims to help cryptogenic stroke patients receive necessary cardiology follow-up to reduce risk of secondary stroke
Collaboration aims to help cryptogenic stroke patients receive necessary cardiology follow-up to reduce risk of secondary stroke
Collaboration aims to help...
03/28/2024
EP Lab Digest

Advertisement

News
03/28/2024

OMRON Healthcare Press Release

OMRON Healthcare Press Release ...
Global heart health leader sets its sights on atrial fibrillation as a priority along with high blood pressure in evolved mission to eliminate heart attack and stroke
Global heart health leader sets its sights on atrial fibrillation as a priority along with high blood pressure in evolved mission to eliminate heart attack and stroke
Global heart health leader sets...
03/28/2024
EP Lab Digest
News
03/28/2024

Thryv Therapeutics Press Release

Thryv Therapeutics Press Release ...
• Treatment with LQT-1213 demonstrated statistically significant and clinically meaningful reductions in dofetilide-induced QTc prolongation. • Larger treatment effects seen in pre-defined subgroups of individuals with largest increases in...
• Treatment with LQT-1213 demonstrated statistically significant and clinically meaningful reductions in dofetilide-induced QTc prolongation. • Larger treatment effects seen in pre-defined subgroups of individuals with largest increases in...
• Treatment with LQT-1213...
03/28/2024
EP Lab Digest
News
03/28/2024

American College of Cardiology Press Release

American College of Cardiology Press ...
Many out-of-hospital cardiac arrests occurred within a four-minute walk of a public AED, yet devices were seldom used
Many out-of-hospital cardiac arrests occurred within a four-minute walk of a public AED, yet devices were seldom used
Many out-of-hospital cardiac...
03/28/2024
EP Lab Digest

Advertisement

News
03/26/2024
EPLive 2024 is a two-day conference that draws the world’s top cardiac electrophysiology experts
EPLive 2024 is a two-day conference that draws the world’s top cardiac electrophysiology experts
EPLive 2024 is a two-day...
03/26/2024
EP Lab Digest
News
03/25/2024

PrepMD Press Release

PrepMD Press Release
BRAINTREE, Mass., March 22, 2024-- PrepMD, the leading provider of cardiac healthcare solutions, and Magnifi Group, Inc., renowned for its educational courses for Orthopedic Fellows, today announced partnership to create and manage an...
BRAINTREE, Mass., March 22, 2024-- PrepMD, the leading provider of cardiac healthcare solutions, and Magnifi Group, Inc., renowned for its educational courses for Orthopedic Fellows, today announced partnership to create and manage an...
BRAINTREE, Mass., March 22,...
03/25/2024
EP Lab Digest
News
03/25/2024

Bristol Myers Squibb Press Release

Bristol Myers Squibb Press Release ...
• Analysis from a 10-month post-launch evaluation of the REMS Program finds 2.8% incidence of LVEF
• Analysis from a 10-month post-launch evaluation of the REMS Program finds 2.8% incidence of LVEF
• Analysis from a 10-month...
03/25/2024
EP Lab Digest

Advertisement

News
03/25/2024

Adagio Medical Press Release

Adagio Medical Press Release
LAGUNA HILLS, Calif., March 25, 2024 /-- Adagio Medical, Inc., a leading innovator in catheter ablation technologies for ventricular tachycardia (VT) and atrial fibrillation (AF), today announced CE Mark approval of its...
LAGUNA HILLS, Calif., March 25, 2024 /-- Adagio Medical, Inc., a leading innovator in catheter ablation technologies for ventricular tachycardia (VT) and atrial fibrillation (AF), today announced CE Mark approval of its...
LAGUNA HILLS, Calif., March...
03/25/2024
EP Lab Digest

Advertisement